|
|
Charles River offers multiple products and services in support of the development, manufacture and analytical testing of vaccines. Our Biopharmaceutical Services group has experience in the manufacture of live and attenuated viral vaccines in both cell- and egg-based expression systems under current Good Manufacturing Practice (cGMP) requirements for both preclinical studies and early-phase clinical trials. We offer testing from release of cell banks and viral stocks to the release of bulk and final vaccine product.
Testing Services
To check which of our BPS facilities perform vaccine testing, click here.
Related Information
For a copy of our Preclinical Vaccine Researcher newsletter and access to our archived vaccine webinars, please log in to The SourceSM. If you are not a member of The SourceSM, our new online scientific and educational information center, please click here to register.
For more information on our capabilities that help support the development and commercialization of vaccines, contact us at 1.877.CRIVER.1 or askcharlesriver@crl.com.
|
Vaccine, vaccines, live vaccine, live vaccines, attenuated, viral vaccines, viral vaccine, current Good Manufacturing Practice, cGMP, viral stocks, Viral seed, vaccine testing
Vaccine Testing | Charles River Biopharmaceutical Services
Charles River has experience in the manufacture of live and attenuated viral vaccines in both cell- and egg-based expression systems under current Good Manufacturing Practice (cGMP) requirements for preclinical studies and early-phase clinical trials.